Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today issued the following statement in response to the Federal Trade Commission's reckless insulin action: ...
UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...
The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines ...
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
The FTC, led by chair Lina Khan, is seeking to ultimately lower insurance premiums as well as wholesale prices, which in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback